BSE filing, NSE: KGPETRO. Summary written from the filing by ALFA Finder's alert engine.
KG Petrochem Ltd: key numbers
- Share price
- ₹185.00
- Market cap
- ₹107.6 Cr
- Revenue (annual)
- ₹313.7 Cr
- Net profit (annual)
- ₹4.45 Cr
- P/E (TTM)
- 38.6×Sector 49.0×
- Promoter holding
- 74.66%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from KG Petrochem Ltd
All →KG Petrochem Other Announcement
KG Petrochem Ltd has filed its quarterly shareholding pattern as per SEBI Regulation 31. This routine disclosure provides the breakdown of shareholding for the quarter.
KG Petrochem Management Change
KG Petrochem Limited announced the re-appointment of three executive directors and a designation change for an independent director.
KG Petrochem Annual General Meeting
KG Petrochem Limited conducted its 46th Annual General Meeting on August 26, 2026, to transact ordinary and special business items, including director re-appointments and corporate guarantees.
KG Petrochem Q1 FY27 Results: Net Profit ₹0.5 Cr, Down 77.3% YoY
KG Petrochem Ltd reported revenue from operations of ₹57.8 Cr (-38.5% YoY) and net profit of ₹0.5 Cr (-77.3% YoY) for Q1 FY27.
- Key figure
- Net profit ₹0.5 Cr · -77.3% YoY
KG Petrochem Board Meeting Date
KG Petrochem Limited has scheduled a board meeting for August 12, 2026, to consider and approve the company's unaudited standalone financial results for the quarter ended June 30, 2026.
KG Petrochem Management Change
KG Petrochem Limited announced the re-appointment of three executive directors and the regularisation of one independent director. These board changes are effective from August 2026 and May 2026.
Other board meeting date announcements
All →Patel Engineering Board Meeting Date
Patel Engineering has scheduled its Board meeting for November 5, 2026, to approve Q1 and H1 FY27 unaudited results. No financial figures or decisions are reported in this advance notice.
GKB Ophthalmics Board Meeting Date
GKB Ophthalmics scheduled its Board Meeting for November 12, 2026. The meeting will consider approving unaudited results for the September 30, 2026 quarter and half year.
Bombay Oxygen Investments Board Meeting Date
Board meeting scheduled for Nov 6, 2026 to approve Q1 and H1 FY27 unaudited results. Trading window closed for insiders Oct 1–Nov 8, 2026.
OCCL Board Meeting Date
OCCL Ltd has scheduled its Board meeting for 6 November 2026 to consider Q1 FY27 unaudited results and a possible interim dividend. The trading window for designated persons closed from 1 October 2026.
TCM Board Meeting Date
TCM Limited intimated a Board meeting for 06/11/2026 to approve Q2 FY27 results. The trading window will reopen 48 hours after the results declaration.
Mercury Laboratories Board Meeting Date
Mercury Laboratories scheduled its Board meeting for November 5, 2026, to approve Q2/H1 FY27 results. Trading window remains closed until 48 hours post-announcement.